Supporting our recently published data using a large breast cancer cohort (22), CD169+ TAMs associated significantly with TLLS also in a small breast cancer tissue array (TMA) test cohort consisting of 23 patients, (Supplementary Table 4; Pearson Chi-Square, Linear by Linear association p=0.048). The gene discussed is SIGLEC1; the disease is breast carcinoma.